Evidence map›Paper›PMID 42309603›Full record

ArticleJournal, genetic engineering & biotechnology2026

Development of a new powdery mildew and Cercospora leaf spot-resistant mungbean cultivar using marker-assisted backcross breeding.

Pakhawat Pookhamsak, Teerayoot Girdthai, Achara Jomsangawong, Arada Masari, Sumana Ngampongsai, Akkawat Tharapreuksapong, Piyada Alisha Tantasawat

Abstract read
In one paragraph

Article in Journal, genetic engineering & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pakhawat PookhamsakSchool of Crop Production Technology, Institute of Agricultural Technology, Suranaree University of Technology, 111 University Avenue, Muang District, Nakhon Ratchasima 30000, Thailand.
Teerayoot GirdthaiSchool of Crop Production Technology, Institute of Agricultural Technology, Suranaree University of Technology, 111 University Avenue, Muang District, Nakhon Ratchasima 30000, Thailand.
Achara JomsangawongChai Nat Field Crops Research Center, Sapphaya, Chai Nat 17150, Thailand.
Arada MasariChai Nat Field Crops Research Center, Sapphaya, Chai Nat 17150, Thailand.
Sumana NgampongsaiChai Nat Field Crops Research Center, Sapphaya, Chai Nat 17150, Thailand.
Akkawat TharapreuksapongCenter for Scientific and Technological Equipment, Suranaree University of Technology, 111 University Avenue, Muang District, Nakhon Ratchasima 30000, Thailand.
Piyada Alisha TantasawatSchool of Crop Production Technology, Institute of Agricultural Technology, Suranaree University of Technology, 111 University Avenue, Muang District, Nakhon Ratchasima 30000, Thailand. Electronic address: piyada@sut.ac.th.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chai Nat 84-1 (CN84-1) is one of the most popular Thai-certified mungbean cultivars widely grown in Thailand, known for its large seeds and high yield. However, this cultivar is susceptible to powdery mildew (PM) and Cercospora leaf spot (CLS). These are the major foliar diseases in mungbean production that can significantly reduce both the quality and quantity of yields. In the present study, the pyramiding of 2 PM and 1 CLS resistance genes from donor parents A and B into elite variety CN84-1 was achieved through marker-assisted backcross breeding (MABB). The progenies pyramided with the three resistance genes in each cross from the BC

Indexed as

Background selectionBroad-spectrum resistanceForeground selectionGene pyramidingRecurrent parent genome (RPG) recovery

Identifiers

PMID42309603
PMCPMC13112393

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.